MedTrace Logo

Local Tranexamic Acid During Vaginal Hysteractomy to Reduce Blood Loss

NCT04760301 · Status: RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 60

Last updated 2025-05-06

No results posted yet for this study

Summary

Assessing the efficiency of Prophylactic use of local tranexamic acid during vaginal hysterectomy to reduce blood loss during operation

Conditions

  • Blood Loss

Interventions

DRUG

local tranexamic acid injection

local tranexamic acid injection to cervix- 1 g tranexamic acid diluted in 10 ml saline

OTHER

local normal saline injection to cervix

local normal saline injection to the cervix- 20 ml saline

Sponsors & Collaborators

  • Meir Medical Center

    lead OTHER

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
DOUBLE
Model
SINGLE_GROUP

Eligibility

Min Age
20 Years
Max Age
90 Years
Sex
FEMALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2021-02-16
Primary Completion
2025-07-31
Completion
2026-06-30

Countries

  • Israel

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04760301 on ClinicalTrials.gov